|
|
|
|
17 * !
|
Sun, 8/8/2021,
1:30 PM -
3:20 PM
|
Virtual
|
|
Innovative Statistical Strategies and Designs in Oncology Drug Development — Topic-Contributed Papers
|
|
Biopharmaceutical Section, Biometrics Section, International Chinese Statistical Association
|
|
Organizer(s): Olga Marchenko, Bayer
|
|
Chair(s): Qi Jiang, Seagen
|
|
1:35 PM
|
Opportunities and Challenges of Master Protocol Trials: ASA Oncology Working Group Master Protocol Subteam Update
Xiaoyun (Nicole) Li, Merck & Co.; Chengxing (Cindy) Lu, Biogen
|
|
1:55 PM
|
Application of Historical Data in Oncology Combination Therapy Development
Rong Liu, Bristol Myers Squibb
|
|
2:15 PM
|
Statistical and Operational Considerations for 2-Stage Adaptive Designs with Simultaneous Evaluation of Overall and Marker Selected Populations in Oncology Confirmatory Trials
Sunhee Ro, Sierra Oncology
|
|
2:35 PM
|
Discussant: Xin Cindy Gao, FDA
|
|
2:55 PM
|
Floor Discussion
|
